Atlas Trials

A Study to Assess Tolerability of the Trivalent Recombinant Vaccine in Individuals Aged 18 and Older Using the Vaccinees Perception of Injection Questionnaire

Clinical trial NCT06765187 · COMPLETED

Trial details

NCT number
NCT06765187
Sponsor
Sanofi
Status
COMPLETED
Study type
OBSERVATIONAL
Influenza ImmunizationHealth Volunteers
Start date
2024-11-18
Primary completion
2025-12-22
Enrollment
1007

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.